| Name | Title | Contact Details |
|---|
Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB and an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find Fight and Follow® serious medical conditions. Lantheus provides a broad portfolio of products, including the echocardiography agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; AZEDRA® for the treatment of certain rare neuroendocrine tumors; and RELISTOR® for the treatment of opioid-induced constipation, which is partnered with Bausch Health Companies, Inc. The Company is headquartered in North Billerica, Massachusetts with offices in New York, New Jersey, Canada and Sweden.
UltraRAD Corp is a West Berlin, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
First Plan Of Minnesota is a Duluth, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Clinical Research Group is a Villanova, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Healthpia America is a Palisades Park, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.